Thomas Unterman, a director at $BL, sold 885 shares of the company on 07-21-2025 for an estimated $50,179. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.9% of their shares of this class of stock. Following this trade, they now own 44,565 shares of this class of $BL stock.
$BL Insider Trading Activity
$BL insiders have traded $BL stock on the open market 11 times in the past 6 months. Of those trades, 1 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $BL stock by insiders over the last 6 months:
- DAVID J HENSHALL purchased 10,000 shares for an estimated $486,000
- THOMAS UNTERMAN has made 0 purchases and 6 sales selling 7,255 shares for an estimated $400,738.
- MICHELLE D STALICK (Chief Accounting Officer) has made 0 purchases and 3 sales selling 1,859 shares for an estimated $101,696.
- MARK WOODHAMS (Chief Revenue Officer) sold 1,856 shares for an estimated $101,430
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BL Hedge Fund Activity
We have seen 140 institutional investors add shares of $BL stock to their portfolio, and 193 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,214,522 shares (-33.6%) from their portfolio in Q2 2025, for an estimated $68,766,235
- FIRST MANHATTAN CO. LLC. added 1,011,943 shares (+124.0%) to their portfolio in Q2 2025, for an estimated $57,296,212
- NEUBERGER BERMAN GROUP LLC added 728,770 shares (+86.0%) to their portfolio in Q2 2025, for an estimated $41,262,957
- BLACKROCK, INC. removed 543,920 shares (-6.3%) from their portfolio in Q2 2025, for an estimated $30,796,750
- ENSIGN PEAK ADVISORS, INC added 500,000 shares (+2460.0%) to their portfolio in Q2 2025, for an estimated $28,310,000
- NUVEEN, LLC removed 398,788 shares (-76.6%) from their portfolio in Q2 2025, for an estimated $22,579,376
- AMERICAN CENTURY COMPANIES INC added 339,666 shares (+35.3%) to their portfolio in Q2 2025, for an estimated $19,231,888
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BL Congressional Stock Trading
Members of Congress have traded $BL stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BL stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 08/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BL Analyst Ratings
Wall Street analysts have issued reports on $BL in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 09/11/2025
- Morgan Stanley issued a "Overweight" rating on 08/06/2025
- Raymond James issued a "Outperform" rating on 07/29/2025
- Citigroup issued a "Buy" rating on 07/16/2025
- Goldman Sachs issued a "Sell" rating on 04/17/2025
- DA Davidson issued a "Buy" rating on 04/14/2025
To track analyst ratings and price targets for $BL, check out Quiver Quantitative's $BL forecast page.
$BL Price Targets
Multiple analysts have issued price targets for $BL recently. We have seen 10 analysts offer price targets for $BL in the last 6 months, with a median target of $60.5.
Here are some recent targets:
- Patrick Walravens from JMP Securities set a target price of $80.0 on 09/11/2025
- Terry Tillman from Truist Securities set a target price of $50.0 on 08/07/2025
- Chris Quintero from Morgan Stanley set a target price of $68.0 on 08/06/2025
- William Jellison from DA Davidson set a target price of $56.0 on 08/06/2025
- Daniel Jester from BMO Capital set a target price of $63.0 on 08/06/2025
- Alexander Sklar from Raymond James set a target price of $67.0 on 07/29/2025
- Steven Enders from Citigroup set a target price of $67.0 on 07/16/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.